{"transactions":[{"id":4636219,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-10-06T20:35:47.000Z","date":"2026-10-02","kind":"exercise","planned":false,"acquired":false,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":3440,"derivative":{"underlying":"Common Stock","underlying_shares":3440},"source":{"system":"sec-edgar","filing":"0001193125-26-415649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526415649/ownership.xml","form_type":"4"}},{"id":4636218,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T20:35:47.000Z","date":"2026-10-02","kind":"exercise","planned":false,"acquired":true,"shares":3440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":141585,"source":{"system":"sec-edgar","filing":"0001193125-26-415649","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526415649/ownership.xml","form_type":"4"}},{"id":713622,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-07T20:05:02.000Z","date":"2026-07-02","kind":"exercise","planned":false,"acquired":false,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":6880,"derivative":{"underlying":"Common Stock","underlying_shares":3440},"source":{"system":"sec-edgar","filing":"0001193125-26-297456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526297456/ownership.xml","form_type":"4"}},{"id":713621,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T20:05:02.000Z","date":"2026-07-02","kind":"exercise","planned":false,"acquired":true,"shares":3440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":138145,"source":{"system":"sec-edgar","filing":"0001193125-26-297456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526297456/ownership.xml","form_type":"4"}},{"id":726255,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-06-25T20:02:49.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":4.08,"value":114240.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors."}],"balance_after":28000,"derivative":{"exercise_price":4.08,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001197032-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000119703226000005/primarydocument.xml","form_type":"4"}},{"id":741730,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:25.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267503/ownership.xml","form_type":"4"}},{"id":784508,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T00:30:21.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":27393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option will vest in full on May 7, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":27393,"derivative":{"exercise_price":18,"expiration_date":"2036-05-06","underlying":"Common Stock","underlying_shares":27393},"source":{"system":"sec-edgar","filing":"0001193125-26-217592","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000119312526217592/ownership.xml","form_type":"4"}},{"id":819650,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:05:06.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":false,"shares":3441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":10320,"derivative":{"underlying":"Common Stock","underlying_shares":3441},"source":{"system":"sec-edgar","filing":"0001193125-26-140056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526140056/ownership.xml","form_type":"4"}},{"id":819649,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T20:05:06.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":true,"shares":3441,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":134705,"source":{"system":"sec-edgar","filing":"0001193125-26-140056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526140056/ownership.xml","form_type":"4"}},{"id":893333,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T21:24:03.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award shall vest as to 1/4 of the total award annually with the first tranche vesting on February 15, 2027, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":129000,"derivative":{"expiration_date":"2030-02-15","underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001197032-26-000002","document":"form4-02192026_090250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000119703226000002/form4-02192026_090250.xml","form_type":"4"}},{"id":893332,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-19T21:24:03.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":193000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/48 of the total award on March 15, 2026, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":193000,"derivative":{"exercise_price":31.09,"expiration_date":"2036-02-16","underlying":"Common Stock","underlying_shares":193000},"source":{"system":"sec-edgar","filing":"0001197032-26-000002","document":"form4-02192026_090250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000119703226000002/form4-02192026_090250.xml","form_type":"4"}},{"id":944543,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-07T21:05:04.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":false,"shares":4573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on January 6, 2025 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on January 6, 2025 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4573},"source":{"system":"sec-edgar","filing":"0001193125-26-006287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526006287/ownership.xml","form_type":"4"}},{"id":944542,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-07T21:05:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":13761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"Smith RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Smith RSUs (as defined in footnote 3) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 2, 2026 (\"the Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Fourth Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Smith RSUs (as defined in footnote 3) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 2, 2026 (\"the Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Fourth Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":13761,"derivative":{"underlying":"Common Stock","underlying_shares":13761},"source":{"system":"sec-edgar","filing":"0001193125-26-006287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526006287/ownership.xml","form_type":"4"}},{"id":944541,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:05:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":18012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Smith RSUs (as defined in footnote 3) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 2, 2026 (\"the Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Fourth Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":18012,"derivative":{"exercise_price":5.45,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":18012},"source":{"system":"sec-edgar","filing":"0001193125-26-006287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526006287/ownership.xml","form_type":"4"}},{"id":944540,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T21:05:04.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":true,"shares":4573,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":131264,"source":{"system":"sec-edgar","filing":"0001193125-26-006287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526006287/ownership.xml","form_type":"4"}},{"id":1019255,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-14T20:16:10.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award shall vest as to 1/4 of the total award annually on the sixth calendar day of October, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 6, 2026."}],"balance_after":380000,"derivative":{"expiration_date":"2029-10-06","underlying":"Common Stock","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001197032-25-000004","document":"form4-10142025_081006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000119703225000004/form4-10142025_081006.xml","form_type":"4"}},{"id":1019254,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-14T20:16:10.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":570000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/4 of the total award on October 6, 2026, with an additional 1/48 of the total award vesting monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":570000,"derivative":{"exercise_price":30.5,"expiration_date":"2035-10-07","underlying":"Common Stock","underlying_shares":570000},"source":{"system":"sec-edgar","filing":"0001197032-25-000004","document":"form4-10142025_081006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000119703225000004/form4-10142025_081006.xml","form_type":"4"}},{"id":1022231,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-07T20:05:03.000Z","date":"2025-10-06","kind":"exercise","planned":false,"acquired":false,"shares":4573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 6, 2025 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 6, 2025 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":4573,"derivative":{"underlying":"Common Stock","underlying_shares":4573},"source":{"system":"sec-edgar","filing":"0001193125-25-233445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312525233445/ownership.xml","form_type":"4"}},{"id":1022230,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T20:05:03.000Z","date":"2025-10-06","kind":"exercise","planned":false,"acquired":true,"shares":4573,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":126692,"source":{"system":"sec-edgar","filing":"0001193125-25-233445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312525233445/ownership.xml","form_type":"4"}},{"id":1090661,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-07-09T00:04:42.000Z","date":"2025-07-06","kind":"exercise","planned":false,"acquired":false,"shares":4573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 6, 2025 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 6, 2025 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":9146,"derivative":{"underlying":"Common Stock","underlying_shares":4573},"source":{"system":"sec-edgar","filing":"0000950170-25-094690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025094690/ownership.xml","form_type":"4"}},{"id":1090660,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-09T00:04:42.000Z","date":"2025-07-06","kind":"exercise","planned":false,"acquired":true,"shares":4573,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":122119,"source":{"system":"sec-edgar","filing":"0000950170-25-094690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025094690/ownership.xml","form_type":"4"}},{"id":1107709,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T20:29:40.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":4.79,"value":119750.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":4.79,"exercise_date":"2026-06-17","expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-25-004909","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000156218025004909/primarydocument.xml","form_type":"4"}},{"id":1111738,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-13T20:28:57.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2025 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":4.58,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0000950170-25-086248","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025086248/ownership.xml","form_type":"4"}},{"id":1175634,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-08T20:05:03.000Z","date":"2025-04-06","kind":"exercise","planned":false,"acquired":false,"shares":4574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 6, 2025 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 6, 2025 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":13719,"derivative":{"underlying":"Common Stock","underlying_shares":4574},"source":{"system":"sec-edgar","filing":"0000950170-25-052050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025052050/ownership.xml","form_type":"4"}},{"id":1175633,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-08T20:05:03.000Z","date":"2025-04-06","kind":"exercise","planned":false,"acquired":true,"shares":4574,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":117546,"source":{"system":"sec-edgar","filing":"0000950170-25-052050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025052050/ownership.xml","form_type":"4"}},{"id":1195686,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T22:19:44.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":238420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests ratably as to 1/12 of the total award on the monthly anniversary of the grant date, subject to the  reporting person's continued service to the Issuer on each vesting date."}],"balance_after":238420,"derivative":{"exercise_price":8.33,"expiration_date":"2035-03-19","underlying":"Common Stock","underlying_shares":238420},"source":{"system":"sec-edgar","filing":"0001415889-25-008715","document":"form4-03202025_100340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008715/form4-03202025_100340.xml","form_type":"4"}},{"id":1308106,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-07T22:28:48.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":18293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"Smith RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 6, 2025 (\"the Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 6, 2025 (\"the Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":18293,"derivative":{"underlying":"Common Stock","underlying_shares":18293},"source":{"system":"sec-edgar","filing":"0000950170-25-003052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025003052/ownership.xml","form_type":"4"}},{"id":1308105,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T22:28:48.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":22148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 6, 2025 (\"the Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":22148,"derivative":{"exercise_price":4.1,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":22148},"source":{"system":"sec-edgar","filing":"0000950170-25-003052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025003052/ownership.xml","form_type":"4"}},{"id":1308104,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-07T22:28:48.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":false,"shares":3255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3255},"source":{"system":"sec-edgar","filing":"0000950170-25-003052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025003052/ownership.xml","form_type":"4"}},{"id":1308103,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T22:28:48.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":true,"shares":3255,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":112972,"source":{"system":"sec-edgar","filing":"0000950170-25-003052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025003052/ownership.xml","form_type":"4"}},{"id":1390796,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-04T20:05:09.000Z","date":"2024-10-03","kind":"exercise","planned":false,"acquired":false,"shares":3255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":3255,"derivative":{"underlying":"Common Stock","underlying_shares":3255},"source":{"system":"sec-edgar","filing":"0000950170-24-112898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024112898/ownership.xml","form_type":"4"}},{"id":1390795,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-04T20:05:09.000Z","date":"2024-10-03","kind":"exercise","planned":false,"acquired":true,"shares":3255,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":109717,"source":{"system":"sec-edgar","filing":"0000950170-24-112898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024112898/ownership.xml","form_type":"4"}},{"id":1458829,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-07-05T20:05:02.000Z","date":"2024-07-03","kind":"exercise","planned":false,"acquired":false,"shares":3255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":6510,"derivative":{"underlying":"Common Stock","underlying_shares":3255},"source":{"system":"sec-edgar","filing":"0000950170-24-081866","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024081866/ownership.xml","form_type":"4"}},{"id":1458828,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-05T20:05:02.000Z","date":"2024-07-03","kind":"exercise","planned":false,"acquired":true,"shares":3255,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":106462,"source":{"system":"sec-edgar","filing":"0000950170-24-081866","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024081866/ownership.xml","form_type":"4"}},{"id":1467076,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-06-28T20:06:35.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":5.52,"value":88320.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":5.52,"exercise_date":"2025-06-26","expiration_date":"2034-06-25","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001562180-24-005361","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000156218024005361/primarydocument.xml","form_type":"4"}},{"id":1480770,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-13T20:11:50.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":34400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":34400,"derivative":{"exercise_price":7.51,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":34400},"source":{"system":"sec-edgar","filing":"0000950170-24-073006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024073006/ownership.xml","form_type":"4"}},{"id":1486723,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-07T20:23:33.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":7639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":7639,"derivative":{"exercise_price":16.41,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":7639},"source":{"system":"sec-edgar","filing":"0001415889-24-015970","document":"form4-06072024_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924015970/form4-06072024_080629.xml","form_type":"4"}},{"id":1546724,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-04-05T20:45:30.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":false,"shares":3256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":9765,"derivative":{"underlying":"Common Stock","underlying_shares":3256},"source":{"system":"sec-edgar","filing":"0000950170-24-042322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024042322/ownership.xml","form_type":"4"}},{"id":1546723,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-05T20:45:30.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":true,"shares":3256,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":103207,"source":{"system":"sec-edgar","filing":"0000950170-24-042322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024042322/ownership.xml","form_type":"4"}},{"id":1685537,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-01-06T00:02:09.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":13021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"Smith RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on the Grant Date and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on the Grant Date and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":13021,"derivative":{"underlying":"Common Stock","underlying_shares":13021},"source":{"system":"sec-edgar","filing":"0000950170-24-002598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024002598/ownership.xml","form_type":"4"}},{"id":1685536,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-06T00:02:09.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":15112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on the Grant Date and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":15112,"derivative":{"exercise_price":5.76,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":15112},"source":{"system":"sec-edgar","filing":"0000950170-24-002598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024002598/ownership.xml","form_type":"4"}},{"id":1685535,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-01-06T00:02:09.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":false,"shares":15570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2024 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15570},"source":{"system":"sec-edgar","filing":"0000950170-24-002598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024002598/ownership.xml","form_type":"4"}},{"id":1685534,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-06T00:02:09.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":true,"shares":15570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":99948,"source":{"system":"sec-edgar","filing":"0000950170-24-002598","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024002598/ownership.xml","form_type":"4"}},{"id":1713879,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-12T21:00:39.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":26977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to a consulting agreement effective December 8, 2023 (the \"Effective Date\"). The option will vest as to 1/12 of the underlying shares of common stock on the first day of each month beginning on January 1, 2024, with the balance of then-unvested shares to vest one year after the Effective Date."}],"balance_after":26977,"derivative":{"exercise_price":5.63,"expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":26977},"source":{"system":"sec-edgar","filing":"0001562180-23-008311","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000156218023008311/primarydocument.xml","form_type":"4"}},{"id":1764349,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-10-05T19:13:54.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":false,"shares":15569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted units convert to common on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the First Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the First Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":15570,"derivative":{"underlying":"Common Stock","underlying_shares":15569},"source":{"system":"sec-edgar","filing":"0000950170-23-052171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017023052171/ownership.xml","form_type":"4"}},{"id":1764348,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T19:13:54.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":true,"shares":15569,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted units convert to common on a one-for-one basis."}],"balance_after":84378,"source":{"system":"sec-edgar","filing":"0000950170-23-052171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017023052171/ownership.xml","form_type":"4"}},{"id":1776199,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-09-20T20:48:01.000Z","date":"2023-09-19","kind":"grant","planned":false,"acquired":true,"shares":96340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests ratably as to 1/12th of the total award on December 19, 2023, with 1/12th of the total award vesting quarterly thereafter, subject to the  reporting person's continued service to the Issuer on each vesting date."}],"balance_after":96340,"derivative":{"exercise_price":4.76,"expiration_date":"2033-09-18","underlying":"Common Stock","underlying_shares":96340},"source":{"system":"sec-edgar","filing":"0001209191-23-050170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123050170/doc4.xml","form_type":"4"}},{"id":1833938,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-06T17:40:14.000Z","date":"2023-07-03","kind":"exercise","planned":false,"acquired":false,"shares":15570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the First Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the First Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":31139,"derivative":{"underlying":"Common Stock","underlying_shares":15570},"source":{"system":"sec-edgar","filing":"0000950170-23-031954","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017023031954/ownership.xml","form_type":"4"}},{"id":1833937,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T17:40:14.000Z","date":"2023-07-03","kind":"exercise","planned":false,"acquired":true,"shares":15570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted units convert into common stock on a one-for-one basis."}],"balance_after":68809,"source":{"system":"sec-edgar","filing":"0000950170-23-031954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017023031954/ownership.xml","form_type":"4"}},{"id":1846310,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T00:13:50.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":8.7,"exercise_date":"2024-06-21","expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001562180-23-005478","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000156218023005478/primarydocument.xml","form_type":"4"}},{"id":1862422,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-09T01:15:28.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 6, 2023 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":9650,"derivative":{"exercise_price":6.37,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0000899243-23-014998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323014998/doc4.xml","form_type":"4"}},{"id":1862421,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-09T01:15:28.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":false,"shares":15569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the First Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the First Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full."}],"balance_after":46709,"derivative":{"underlying":"Common Stock","underlying_shares":15569},"source":{"system":"sec-edgar","filing":"0000899243-23-014998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323014998/doc4.xml","form_type":"4"}},{"id":1862420,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T01:15:28.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":true,"shares":15569,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":53239,"source":{"system":"sec-edgar","filing":"0000899243-23-014998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323014998/doc4.xml","form_type":"4"}},{"id":2062821,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-06T02:46:01.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":62278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"Smith RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the First Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the First Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":62278,"derivative":{"underlying":"Common Stock","underlying_shares":62278},"source":{"system":"sec-edgar","filing":"0000899243-23-001134","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323001134/doc4.xml","form_type":"4"}},{"id":2062820,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T02:46:01.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":70796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the \"Smith Equity Awards\") were granted on January 3, 2023 (the \"Grant Date\") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the First Amendment to Executive Chair Agreement between the Issuer and the reporting person (the \"Smith Agreement\") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full."}],"balance_after":70796,"derivative":{"exercise_price":5.62,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":70796},"source":{"system":"sec-edgar","filing":"0000899243-23-001134","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323001134/doc4.xml","form_type":"4"}},{"id":2062819,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-06T02:46:01.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":1620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vested in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vested in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1620},"source":{"system":"sec-edgar","filing":"0000899243-23-001134","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323001134/doc4.xml","form_type":"4"}},{"id":2062818,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-06T02:46:01.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":1620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":37670,"source":{"system":"sec-edgar","filing":"0000899243-23-001134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323001134/doc4.xml","form_type":"4"}},{"id":2085165,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-12-15T23:15:58.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":9650,"derivative":{"exercise_price":6.47,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0000899243-22-038696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924322038696/doc4.xml","form_type":"4"}},{"id":2096199,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-05T23:02:44.000Z","date":"2022-12-02","kind":"grant","acquired":true,"shares":13172,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired 13,172 shares of the issuer's common stock pursuant to the issuer's acquisition of all of the outstanding capital stock of AavantiBio, Inc. on December 2, 2022."}],"balance_after":356380,"source":{"system":"sec-edgar","filing":"0000899243-22-037693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924322037693/doc4.xml","form_type":"4"}},{"id":2144763,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-10-04T20:50:30.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":24312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the award will accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the award will accelerate in full."}],"balance_after":24312,"derivative":{"underlying":"Common Stock","underlying_shares":24312},"source":{"system":"sec-edgar","filing":"0001209191-22-052331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122052331/doc4.xml","form_type":"4"}},{"id":2144762,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T20:50:30.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":24312,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":343208,"source":{"system":"sec-edgar","filing":"0001209191-22-052331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122052331/doc4.xml","form_type":"4"}},{"id":2212046,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-06T20:40:15.000Z","date":"2022-07-03","kind":"exercise","acquired":false,"shares":24313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the award will accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the award will accelerate in full."}],"balance_after":48624,"derivative":{"underlying":"Common Stock","underlying_shares":24313},"source":{"system":"sec-edgar","filing":"0001209191-22-041164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122041164/doc4.xml","form_type":"4"}},{"id":2212045,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T20:40:15.000Z","date":"2022-07-03","kind":"exercise","acquired":true,"shares":24313,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":318896,"source":{"system":"sec-edgar","filing":"0001209191-22-041164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122041164/doc4.xml","form_type":"4"}},{"id":2223945,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-06-23T01:00:06.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":13.81,"exercise_date":"2023-06-21","expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001562180-22-005317","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000156218022005317/primarydocument.xml","form_type":"4"}},{"id":2237815,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-09T21:12:08.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 7, 2022 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":51000,"derivative":{"exercise_price":0.625,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001209191-22-035463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122035463/doc4.xml","form_type":"4"}},{"id":2304581,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-05T20:32:28.000Z","date":"2022-04-03","kind":"exercise","acquired":false,"shares":24313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule will accelerate in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 3, 2022 and vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule will accelerate in full."}],"balance_after":72937,"derivative":{"underlying":"Common Stock","underlying_shares":24313},"source":{"system":"sec-edgar","filing":"0001209191-22-023040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122023040/doc4.xml","form_type":"4"}},{"id":2304580,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T20:32:28.000Z","date":"2022-04-03","kind":"exercise","acquired":true,"shares":24313,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":294583,"source":{"system":"sec-edgar","filing":"0001209191-22-023040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122023040/doc4.xml","form_type":"4"}},{"id":2444074,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-05T22:22:37.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":97250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 3, 2022 and vest on the same schedule as set forth in footnote (1) above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 3, 2022 and vest on the same schedule as set forth in footnote (1) above."}],"balance_after":97250,"derivative":{"underlying":"Common Stock","underlying_shares":97250},"source":{"system":"sec-edgar","filing":"0001209191-22-001816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122001816/doc4.xml","form_type":"4"}},{"id":2444073,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-01-05T22:22:37.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":194500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 3, 2022 pursuant to a services agreement between the reporting person and the Issuer and will vest in equal quarterly installments beginning three\nmonths from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in\ncontrol, the vesting schedule of the option will accelerate in full."}],"balance_after":194500,"derivative":{"exercise_price":1.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":194500},"source":{"system":"sec-edgar","filing":"0001209191-22-001816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122001816/doc4.xml","form_type":"4"}},{"id":2655691,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-06-24T20:58:22.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":12530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to a consulting agreement effective June 23, 2021 (the \"Effective Date\").  The option will vest as to 1/12 of the underlying shares of common stock on the first day of each month beginning on August 1, 2021, with the balance of then-unvested shares to vest one year after the Effective Date."}],"balance_after":12530,"derivative":{"exercise_price":10.24,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":12530},"source":{"system":"sec-edgar","filing":"0001562180-21-004483","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000156218021004483/primarydocument.xml","form_type":"4"}},{"id":2661168,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-21T20:00:24.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 16, 2021 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":30000,"derivative":{"exercise_price":3.94,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-041938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121041938/doc4.xml","form_type":"4"}},{"id":2735672,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-04-29T21:01:26.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":25060,"price":11.5,"value":288190.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest as to 25% of the underlying shares of common stock on April 27, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested."}],"balance_after":25060,"derivative":{"exercise_price":11.5,"expiration_date":"2031-04-26","underlying":"Common Stock","underlying_shares":25060},"source":{"system":"sec-edgar","filing":"0001562180-21-003018","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197032/000156218021003018/primarydocument.xml","form_type":"4"}},{"id":2915939,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T21:06:11.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":389000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 4, 2021 and will vest in equal quarterly installments beginning three months from the date of the grant with the final installment vesting date being the later of the completion of a specified service requirement under his consulting agreement or 12 months from the date of the grant, subject to continued service as a director or consultant, and in the event of a change in control, the vesting schedule of the option will accelerate in full."}],"balance_after":389000,"derivative":{"exercise_price":7.84,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":389000},"source":{"system":"sec-edgar","filing":"0001209191-21-001966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121001966/doc4.xml","form_type":"4"}},{"id":2946723,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-14T21:22:53.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":270270,"price":3.7,"value":999999.0,"ownership":{"direct":true},"balance_after":270270,"source":{"system":"sec-edgar","filing":"0001209191-20-063218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120063218/doc4.xml","form_type":"4"}},{"id":3105625,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-18T20:28:08.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 16, 2020 and will vest in equal quarterly installments beginning three months from the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":200000,"derivative":{"exercise_price":3.03,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-037594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120037594/doc4.xml","form_type":"4"}},{"id":3175322,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-04-16T11:28:34.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 15, 2020 and vests as to one-third of the total number of shares on each of the next three anniversaries of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":2.49,"expiration_date":"2030-04-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-024599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120024599/doc4.xml","form_type":"4"}},{"id":413686,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-03T20:25:08.000Z","date":"2018-06-29","kind":"exercise","acquired":false,"shares":23375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in 16 quarterly installments from 7/21/2015."}],"balance_after":10625,"derivative":{"exercise_price":131.89,"expiration_date":"2025-07-20","underlying":"Common Stock","underlying_shares":23375},"source":{"system":"sec-edgar","filing":"0001209191-18-041074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118041074/doc4.xml","form_type":"4"}},{"id":413685,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-07-03T20:25:08.000Z","date":"2018-06-29","kind":"sale","acquired":false,"shares":18634,"price":166.57,"value":3103865.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $166.57 (range $166.38 to $166.67)."}],"balance_after":46699,"source":{"system":"sec-edgar","filing":"0001209191-18-041074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118041074/doc4.xml","form_type":"4"}},{"id":413684,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-07-03T20:25:08.000Z","date":"2018-06-29","kind":"sale","acquired":false,"shares":4741,"price":165.22,"value":783308.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $165.22 (range $165.00 to $165.89)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":65333,"source":{"system":"sec-edgar","filing":"0001209191-18-041074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118041074/doc4.xml","form_type":"4"}},{"id":413683,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-07-03T20:25:08.000Z","date":"2018-06-29","kind":"exercise","acquired":true,"shares":23375,"price":131.89,"value":3082928.75,"ownership":{"direct":true},"balance_after":70074,"source":{"system":"sec-edgar","filing":"0001209191-18-041074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118041074/doc4.xml","form_type":"4"}},{"id":3880778,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2018-06-29T07:52:39.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 27, 2018, with the first quarterly installment vesting on September 27, 2018."}],"balance_after":15000,"derivative":{"exercise_price":28.15,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-039999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118039999/doc4.xml","form_type":"4"}},{"id":413911,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-26T21:18:57.000Z","date":"2018-06-22","kind":"exercise","acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 02/03/2015."}],"balance_after":12750,"derivative":{"exercise_price":109.14,"expiration_date":"2025-02-02","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001209191-18-039524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118039524/doc4.xml","form_type":"4"}},{"id":413910,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-06-26T21:18:57.000Z","date":"2018-06-22","kind":"sale","acquired":false,"shares":4250,"price":160,"value":680000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1."}],"balance_after":46699,"source":{"system":"sec-edgar","filing":"0001209191-18-039524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118039524/doc4.xml","form_type":"4"}},{"id":413909,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-06-26T21:18:57.000Z","date":"2018-06-22","kind":"exercise","acquired":true,"shares":4250,"price":109.14,"value":463845.0,"ownership":{"direct":true},"balance_after":50949,"source":{"system":"sec-edgar","filing":"0001209191-18-039524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118039524/doc4.xml","form_type":"4"}},{"id":3889520,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2018-06-19T16:19:53.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercises and sales pursuant to a 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to these options vested in installments and were fully vested on 5/31/2018."}],"balance_after":0,"derivative":{"exercise_price":13.8,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-038543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118038543/doc4.xml","form_type":"4"}},{"id":3889519,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2018-06-19T16:19:53.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercises and sales pursuant to a 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to these options vested in installments and were fully vested on 6/22/2010."}],"balance_after":0,"derivative":{"exercise_price":25.45,"expiration_date":"2019-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-038543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118038543/doc4.xml","form_type":"4"}},{"id":3889518,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-19T16:19:53.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":25000,"price":31.4227,"value":785567.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercises and sales pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.15 to $31.55 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-038543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118038543/doc4.xml","form_type":"4"}},{"id":3889517,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-19T16:19:53.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":15000,"price":13.8,"value":207000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercises and sales pursuant to a 10b5-1 plan."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-18-038543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118038543/doc4.xml","form_type":"4"}},{"id":3889516,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-19T16:19:53.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":10000,"price":25.45,"value":254500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercises and sales pursuant to a 10b5-1 plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-038543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118038543/doc4.xml","form_type":"4"}},{"id":3894262,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-14T08:34:48.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as Chair of the Audit Committee of the issuer's Board of Directors."}],"balance_after":4000,"derivative":{"exercise_price":1.75,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-18-016532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318016532/doc4.xml","form_type":"4"}},{"id":3894261,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-14T08:34:48.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer."}],"balance_after":20000,"derivative":{"exercise_price":1.75,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-18-016532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318016532/doc4.xml","form_type":"4"}},{"id":3894260,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-14T08:34:48.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":22857,"price":1.75,"value":39999.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the issuer's non-employee director compensation program, the reporting person has elected to receive this grant of shares in lieu of cash as payment of such person's $40,000 annual retainer for service as a director."}],"balance_after":45845,"source":{"system":"sec-edgar","filing":"0000899243-18-016532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318016532/doc4.xml","form_type":"4"}},{"id":414919,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-05-16T21:21:39.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":217,"price":155.78,"value":33804.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1."}],"balance_after":46699,"source":{"system":"sec-edgar","filing":"0001209191-18-030604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118030604/doc4.xml","form_type":"4"}},{"id":414979,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T20:21:25.000Z","date":"2018-05-11","kind":"exercise","acquired":false,"shares":1941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 16 quarterly installments from 2/3/2017."}],"balance_after":21358,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":1941},"source":{"system":"sec-edgar","filing":"0001209191-18-030207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118030207/doc4.xml","form_type":"4"}},{"id":414978,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T20:21:25.000Z","date":"2018-05-11","kind":"exercise","acquired":false,"shares":2155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 2/2/2016."}],"balance_after":15086,"derivative":{"exercise_price":91.05,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":2155},"source":{"system":"sec-edgar","filing":"0001209191-18-030207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118030207/doc4.xml","form_type":"4"}},{"id":414977,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-05-15T20:21:25.000Z","date":"2018-05-11","kind":"sale","acquired":false,"shares":4096,"price":155,"value":634880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1."}],"balance_after":46699,"source":{"system":"sec-edgar","filing":"0001209191-18-030207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118030207/doc4.xml","form_type":"4"}},{"id":414976,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-05-15T20:21:25.000Z","date":"2018-05-11","kind":"exercise","acquired":true,"shares":1941,"price":86.52,"value":167935.32,"ownership":{"direct":true},"balance_after":50795,"source":{"system":"sec-edgar","filing":"0001209191-18-030207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118030207/doc4.xml","form_type":"4"}},{"id":414975,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2018-05-15T20:21:25.000Z","date":"2018-05-11","kind":"exercise","acquired":true,"shares":2155,"price":91.05,"value":196212.75,"ownership":{"direct":true},"balance_after":48854,"source":{"system":"sec-edgar","filing":"0001209191-18-030207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118030207/doc4.xml","form_type":"4"}},{"id":3945970,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2018-05-04T17:50:21.000Z","date":"2018-05-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2018 on the expiration date reported within Table II unless exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to these options vested in installments and were fully vested on 05/21/2009."}],"balance_after":0,"derivative":{"exercise_price":20.16,"expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-028179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118028179/doc4.xml","form_type":"4"}},{"id":3945969,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-04T17:50:21.000Z","date":"2018-05-02","kind":"sale","acquired":false,"shares":6323,"price":23.8648,"value":150897.1304,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2018 on the expiration date reported within Table II unless exercised."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $23.7750 to $24.0500 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-028179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118028179/doc4.xml","form_type":"4"}}],"next_cursor":"2018-05-04T17:50:21.000000Z,3945969"}